BGM Group Ltd. (BGM) stock
BGMNasdaqPharmaceutical PreparationsFiscal year ends September 30
$8.01+0.13 (+1.71%)
Close on Nov 16, 2026Market cap $3.21BP/E –Yield –
BGM ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$11.12M, down 1751.0% from the year before. The highest annual figure on record is $7.37M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$11.12M | -1751.0% |
| FY2024 | Sep 30, 2024 | $673.46K | – |
| FY2023 | Sep 30, 2023 | -$1.47M | -144.1% |
| FY2022 | Sep 30, 2022 | $3.33M | -7.3% |
| FY2021 | Sep 30, 2021 | $3.59M | -39.3% |
| FY2020 | Sep 30, 2020 | $5.92M | -19.7% |
| FY2019 | Sep 30, 2019 | $7.37M | +2.0% |
| FY2018 | Sep 30, 2018 | $7.23M | – |
See a number that looks wrong?